Abstract
At the request of the Editor and Sage, the following article has been retracted:
Jiang H, Li Y, Li J, et al. Long noncoding RNA LSINCT5 promotes endometrial carcinoma cell proliferation, cycle, and invasion by promoting the Wnt/β-catenin signaling pathway via HMGA2. Therapeutic Advances in Medical Oncology. 2019;11. doi:10.1177/1758835919874649
Sage was made aware of concerns raised on PubPeer regarding the figures in the article. Concerns were raised that several figures in the article appear highly similar to ones in several other publications 1-11 despite different experimental conditions being described.
Concerns were raised about the following figure and tables in the article:
Figure 5A and B
Table 1
Table 2
During an internal investigation, Sage has also become aware that the submission contains indicators of third-party involvement.
We contacted the authors for comment and request they provide the raw images and data underlying this research. The authors were unable to provide the raw images and requested a retraction.
This article has been retracted due to the unresolved issues surrounding the figures in this article.
The authors did not respond when notified of this decision.
1. Zhao D, Zhang H, Long J, Li M. RETRACTED ARTICLE: LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression. Onco Targets Ther. 2020;13:1677-1689 https://doi.org/10.2147/OTT.S237802
2. Hou A, Toh LX, Gan KH, Lee KJR, Manser E, et al. (2013) Rho GTPases and Regulation of Cell Migration and Polarization in Human Corneal Epithelial Cells. PLOS ONE 8(10): e77107. https://doi.org/10.1371/journal.pone.0077107
3. Liu J, Huang S, Liao X, Chen Z, Li L, Yu L, Zhan W, Li R. RETRACTED ARTICLE: LncRNA EWSAT1 Promotes Colorectal Cancer Progression Through Sponging miR-326 to Modulate FBXL20 Expression. Onco Targets Ther. 2021;14:367-378 https://doi.org/10.2147/OTT.S272895
4. Wang, Y., Yin, Y., Zhou, H., & Cao, Y. (2018). miR-639 is associated with advanced cancer stages and promotes proliferation and migration of nasopharyngeal carcinoma. Oncology Letters, 16, 6903-6909. https://doi.org/10.3892/ol.2018.9512
5. Sun T, Liu Z, Zhang R, Ma S, Lin T, Li Y, Yang S, Zhang W, Wang Y. RETRACTED ARTICLE: Long Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis. Onco Targets Ther. 2020;13:2957-2972 https://doi.org/10.2147/OTT.S232839
6. Yang M, Li Y, Wei W. RETRACTED ARTICLE: MicroRNA-188-5p Promotes Epithelial–Mesenchymal Transition by Targeting ID4 Through Wnt/β-catenin Signaling in Retinoblastoma. Onco Targets Ther. 2019;12:10251-10262 https://doi.org/10.2147/OTT.S229739
7. Hong, B., Zhang, J., & Yang, W. (2018). Activation of the LKB1-SIK1 signaling pathway inhibits the TGF-β-mediated epithelial-mesenchymal transition and apoptosis resistance of ovarian carcinoma cells. Molecular Medicine Reports, 17, 2837-2844. https://doi.org/10.3892/mmr.2017.8229
8. Wang Y, Jiang F, Xiong Y, Cheng X, Qiu Z, Song R. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15. Life Sci. 2020 Mar 1;244:116936. doi: 10.1016/j.lfs.2019.116936. Epub 2019 Oct 11. PMID: 31610194.
9. You, S., Li, W., & Guan, Y. (2018). Tunicamycin inhibits colon carcinoma growth and aggressiveness via modulation of the ERK-JNK-mediated AKT/mTOR signaling pathway. Molecular Medicine Reports, 17, 4203-4212. https://doi.org/10.3892/mmr.2018.8444
10. Xie F, He C, Gao S, Yang Z, Li L, Qiao L, Fang L. RETRACTED ARTICLE: KIF20A silence inhibits the migration, invasion and proliferation of non-small cell lung cancer and regulates the JNK pathway. Clin Exp Pharmacol Physiol. 2020 Jan;47(1):135-142. doi: 10.1111/1440-1681.13183. Epub 2019 Oct 22. PMID: 31557334.
11. Lei D, Zhang F, Yao D, Xiong N, Jiang X, Zhao H. MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1. Biomed Pharmacother. 2017 May;89:957-965. doi: 10.1016/j.biopha.2017.01.137. Epub 2017 Mar 9. PMID: 28292024.